Literature DB >> 12161078

The ERK cascade, a new pathway involved in the activation of store-mediated calcium entry in human platelets.

Juan A Rosado1, Stewart O Sage.   

Abstract

Store-mediated Ca(2+) entry (SMCE) is the main pathway for Ca(2+) influx in platelets and other nonexcitable cells, yet how depletion of the intracellular Ca(2+) stores leads to the activation of Ca(2+) entry across the plasma membrane remains unclear. Recent work in platelets favors a secretionlike conformational coupling mechanism involving the Ca(2+)-permeable channel protein, Trp1, in the plasma membrane and the type-II inositol 1,4,5-trisphosphate receptor in the membrane of the Ca(2+) store, which is located in the endoplasmic reticulum. Extracellular signal-regulated kinases (ERKs) are common participants in a broad variety of signal transduction pathways in human platelets, and inactivation of the ERK cascade has been shown to reduce Ca(2+) entry stimulated by thapsigargin or thrombin. The role of ERK in SMCE into human platelets was found to be independent of the cytoskeleton and a downstream effector of the small guanosine-triphosphate-binding protein Ras.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161078     DOI: 10.1016/s1050-1738(02)00161-5

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  7 in total

1.  PAR-1-stimulated factor IXa binding to a small platelet subpopulation requires a pronounced and sustained increase of cytoplasmic calcium.

Authors:  Fredda S London; Mariola Marcinkiewicz; Peter N Walsh
Journal:  Biochemistry       Date:  2006-06-13       Impact factor: 3.162

2.  Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization.

Authors:  M C Chang; B J Uang; C Y Tsai; H L Wu; B R Lin; C S Lee; Y J Chen; C H Chang; Y L Tsai; C J Kao; J H Jeng
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

3.  Inhibitory Effects of Cytosolic Ca(2+) Concentration by Ginsenoside Ro Are Dependent on Phosphorylation of IP3RI and Dephosphorylation of ERK in Human Platelets.

Authors:  Hyuk-Woo Kwon; Jung-Hae Shin; Dong-Ha Lee; Hwa-Jin Park
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-19       Impact factor: 2.629

4.  Activation of ERK1/2 by store-operated calcium entry in rat parotid acinar cells.

Authors:  Stephen P Soltoff; William A Lannon
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

Review 5.  Possible Molecular Targets of Novel Ruthenium Complexes in Antiplatelet Therapy.

Authors:  Thanasekaran Jayakumar; Chia-Yuan Hsu; Themmila Khamrang; Chih-Hsuan Hsia; Chih-Wei Hsia; Manjunath Manubolu; Joen-Rong Sheu
Journal:  Int J Mol Sci       Date:  2018-06-20       Impact factor: 5.923

6.  Inhibitory effects of thromboxane A2 generation by ginsenoside Ro due to attenuation of cytosolic phospholipase A2 phosphorylation and arachidonic acid release.

Authors:  Jung-Hae Shin; Hyuk-Woo Kwon; Man Hee Rhee; Hwa-Jin Park
Journal:  J Ginseng Res       Date:  2018-01-09       Impact factor: 6.060

7.  In Vitro Antiplatelet Activity of Mulberroside C through the Up-Regulation of Cyclic Nucleotide Signaling Pathways and Down-Regulation of Phosphoproteins.

Authors:  Hyuk-Woo Kwon; Dong-Ha Lee; Man Hee Rhee; Jung-Hae Shin
Journal:  Genes (Basel)       Date:  2021-06-30       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.